Savara (SVRA) Assets (2010 - 2026)
Savara (SVRA) reported Assets of $221.6 million for Q1 2026, up 17.08% year-over-year from $189.3 million in Q1 2025, and down 12.54% quarter-over-quarter from $253.4 million in Q4 2025.
Savara (SVRA) Assets (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Assets data on file, last reported at $221.6 million in Q1 2026.
- Assets for Q1 2026 came in at $221.6 million, up 17.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $221.6 million (up 17.08% YoY), and the FY2025 annual result was $253.4 million, up 19.05% from the prior year.
- Assets fell to $221.6 million in Q1 2026 per SVRA's latest filing, from $253.4 million in the prior quarter.
- Over five years, Assets peaked at $253.4 million in Q4 2025 and troughed at $119.8 million in Q2 2023.
- A 5-year average of $172.8 million and a median of $163.8 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets surged 31.17% in 2024, then slumped 40.99% in 2025.
- A 5-year view of Assets shows it stood at $139.8 million in 2022, then grew by 27.03% to $177.6 million in 2023, then climbed by 19.89% to $212.9 million in 2024, then climbed by 19.05% to $253.4 million in 2025, then slipped by 12.54% to $221.6 million in 2026.
- Business Quant data shows SVRA's Assets at $221.6 million in Q1 2026, $253.4 million in Q4 2025, and $140.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | 221.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221.65 Mn |
| Dec 31, 2025 | 253.44 Mn |
| Sep 30, 2025 | 140.92 Mn |
| Jun 30, 2025 | 163.77 Mn |
| Mar 31, 2025 | 189.32 Mn |
| Dec 31, 2024 | 212.88 Mn |
| Sep 30, 2024 | 238.82 Mn |
| Jun 30, 2024 | 139.67 Mn |
| Mar 31, 2024 | 158.30 Mn |
| Dec 31, 2023 | 177.56 Mn |
| Sep 30, 2023 | 182.07 Mn |
| Jun 30, 2023 | 119.83 Mn |
| Mar 31, 2023 | 129.36 Mn |
| Dec 31, 2022 | 139.78 Mn |
| Sep 30, 2022 | 147.76 Mn |
| Jun 30, 2022 | 156.78 Mn |
| Mar 31, 2022 | 166.21 Mn |
| Dec 31, 2021 | 176.60 Mn |
| Sep 30, 2021 | 187.27 Mn |
| Jun 30, 2021 | 196.43 Mn |